HomeABNX • EPA
add
Abionyx Pharma SA
Previous close
€4.29
Day range
€4.03 - €4.51
Year range
€1.09 - €5.29
Market cap
140.72M EUR
Avg Volume
440.97K
P/E ratio
-
Dividend yield
-
Primary exchange
EPA
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 1.06M | -9.60% |
Operating expense | 1.28M | 5.40% |
Net income | -1.15M | -10.44% |
Net profit margin | -108.82 | -22.16% |
Earnings per share | — | — |
EBITDA | -1.13M | -10.53% |
Effective tax rate | -0.35% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.38M | -36.37% |
Total assets | 13.06M | -15.49% |
Total liabilities | 7.56M | 25.82% |
Total equity | 5.50M | — |
Shares outstanding | 34.93M | — |
Price to book | 26.81 | — |
Return on assets | -22.29% | — |
Return on capital | -30.28% | — |
Cash Flow
Net change in cash
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -1.15M | -10.44% |
Cash from operations | -848.00K | 9.50% |
Cash from investing | -81.00K | -500.00% |
Cash from financing | 998.50K | -35.66% |
Net change in cash | 69.50K | -88.45% |
Free cash flow | -598.19K | -11.77% |
About
Founded
2005
Website
Employees
51
